Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PLCG2 mutation
i
Other names:
PLCG2, Phospholipase C Gamma 2, 1-Phosphatidylinositol 4,5-Bisphosphate Phosphodiesterase Gamma-2, Phospholipase C, Gamma 2 (Phosphatidylinositol-Specific), Phosphoinositide Phospholipase C-Gamma-2, Phospholipase C-IV, PLC-Gamma-2, PLC-IV, Phospholipase C-Gamma-2, APLAID, FCAS3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5336
Related biomarkers:
Mutation
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PLCG2 mutation
Follicular Lymphoma
PLCG2 mutation
Follicular Lymphoma
Resistant: C3 – Early Trials
Resistant
:
C3
Resistant: C3 – Early Trials
Resistant
:
C3
PLCG2 mutation
Myelodysplastic Syndrome
PLCG2 mutation
Myelodysplastic Syndrome
lenalidomide
Resistant: C3 – Early Trials
lenalidomide
Resistant
:
C3
lenalidomide
Resistant: C3 – Early Trials
lenalidomide
Resistant
:
C3
PLCG2 mutation
Chronic Lymphocytic Leukemia
PLCG2 mutation
Chronic Lymphocytic Leukemia
venetoclax
Sensitive: C3 – Early Trials
venetoclax
Sensitive
:
C3
venetoclax
Sensitive: C3 – Early Trials
venetoclax
Sensitive
:
C3
PLCG2 mutation
Chronic Lymphocytic Leukemia
PLCG2 mutation
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.